Contact Us: 01282 426380
KM Financial Solutions | Sumitomo Dainippon Pharma to invest $3 bln in Swiss Roivant
50504
post-template-default,single,single-post,postid-50504,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Sumitomo Dainippon Pharma to invest $3 bln in Swiss Roivant

05 Sep Sumitomo Dainippon Pharma to invest $3 bln in Swiss Roivant

Posted at 05:41h in News by
0 Likes
Japan’s Sumitomo Dainippon Pharma
Co will pay $3 billion for a 10% stake in Swiss
drugmaker Roivant Sciences Ltd and interests in five of its
biopharmaceutical businesses, the two companies said on Friday.

No Comments

Sorry, the comment form is closed at this time.